3-methylcholanthrene has been researched along with transforming growth factor beta in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Razzak, Z; Campion, JP; Corcos, L; Fautrel, A; Guillouzo, A | 1 |
| Chang, HL; Derynck, R; Figari, I; Gillett, N; Lopez, AR; Palladino, MA | 1 |
| Bauer, G; Hipp, ML; Panse, J | 1 |
| Klaassen, CD; Kolaja, KL | 1 |
| Chin, JY; Leister, KJ; Wenner, CE | 1 |
| Chamoto, K; Kitamura, H; Matsushima, K; Nishimura, T; Ohkuri, T; Uchinami, Y; Wakita, D | 1 |
6 other study(ies) available for 3-methylcholanthrene and transforming growth factor beta
| Article | Year |
|---|---|
Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
Topics: Adult; Amino Acid Sequence; Base Sequence; Benzo(a)pyrene; Cells, Cultured; Cycloheximide; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Induction; Humans; Kinetics; Liver; Methylcholanthrene; Molecular Sequence Data; Nuclear Proteins; Oligodeoxyribonucleotides; Oxidoreductases; RNA, Messenger; Transcription Factor AP-1; Transcription, Genetic; Transforming Growth Factor beta | 1994 |
Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
Topics: Animals; Cell Division; Female; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sarcoma, Experimental; Splenomegaly; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |
Fibroblasts transformed by chemical carcinogens are sensitive to intercellular induction of apoptosis: implications for the control of oncogenesis.
Topics: Animals; Apoptosis; Carcinogens; Cell Communication; Cell Count; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; DNA Fragmentation; Fibroblasts; Methylcholanthrene; Methylnitronitrosoguanidine; Quercetin; Transforming Growth Factor beta; Tumor Stem Cell Assay | 1997 |
Dose-response examination of UDP-glucuronosyltransferase inducers and their ability to increase both TGF-beta expression and thyroid follicular cell apoptosis.
Topics: Animals; Apoptosis; Chlorodiphenyl (54% Chlorine); Dose-Response Relationship, Drug; Enzyme Induction; Glucuronosyltransferase; Immunohistochemistry; Male; Methylcholanthrene; Phenobarbital; Pregnenolone Carbonitrile; Rats; Rats, Sprague-Dawley; Thyroid Gland; Transforming Growth Factor beta | 1998 |
Density differential responses of embryonic fibroblasts.
Topics: Animals; Cell Count; Cell Culture Techniques; Cell Division; Cell Line, Transformed; Embryo, Mammalian; Fibroblasts; Methylcholanthrene; Mice; Mice, Inbred C3H; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
3-Methylcholanthrene-induced transforming growth factor-beta-producing carcinomas, but not sarcomas, are refractory to regulatory T cell-depletion therapy.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Female; Interleukin-2 Receptor alpha Subunit; Lymphocyte Depletion; Methylcholanthrene; Mice; Mice, Inbred BALB C; Sarcoma; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Escape | 2010 |